The univariate analysis revealed that the prognosis of patients with GIST was related to FABP4 expression (p < 0.001), tumor size (p = 0.026), mitotic index (p = 0.027), and AFIP‐Miettinen risk levels (p < 0.001). Here, FABP4 is linked to gastrointestinal stromal tumor.